The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 13 December 2005 doi:10.1084/jem.20050126
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 12, 1649-1658
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 401K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flores-Villanueva, P. O.
Right arrow Articles by Granados, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flores-Villanueva, P. O.
Right arrow Articles by Granados, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis

Pedro O. Flores-Villanueva1, Jorge A. Ruiz-Morales1, Chang-Hwa Song2, Ludmila M. Flores3, Eun-Kyeong Jo2, Marta Montaño4, Peter F. Barnes1, Moises Selman4, and Julio Granados5

1 Center for Biomedical Research, University of Texas Health Center at Tyler, Tyler, TX 75708
2 Department of Microbiology, College of Medicine, Chungnam National University, Daejeon 301-747, South Korea
3 Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115
4 Mexican Institute of Respiratory Diseases, Mexico D.F. 14080, Mexico
5 Department of Immunology and Rheumatology, Mexican National Institute of Medicine and Nutrition "Salvador Zubiran," Mexico D.F. 14000, Mexico

CORRESPONDENCE Pedro O. Flores-Villanueva: pedro.flores{at}UTHCT.edu

We examined the distribution of single nucleotide polymorphisms (SNPs) in nitric oxide synthase 2A, monocyte chemoattractant protein–1 (MCP-1), regulated on activation, normal T cell expressed and secreted, and macrophage inflammatory protein–1{alpha} genes in tuberculosis patients and healthy controls from Mexico. The odds of developing tuberculosis were 2.3- and 5.4-fold higher in carriers of MCP-1 genotypes AG and GG than in homozygous AA. Cases of homozygous GG had the highest plasma levels of MCP-1 and the lowest plasma levels of IL-12p40, and these values were negatively correlated. Furthermore, stimulation of monocytes from healthy carriers of the genotype GG with Mycobacterium tuberculosis antigens yielded higher MCP-1 and lower IL-12p40 concentrations than parallel experiments with monocytes from homozygous AA. Addition of anti–MCP-1 increased IL-12p40 levels in cultures of M. tuberculosis–stimulated monocytes from homozygous GG, and addition of exogenous MCP-1 reduced IL-12p40 production by M. tuberculosis–stimulated monocytes from homozygous AA. Furthermore, we could replicate our results in Korean subjects, in whom the odds of developing tuberculosis were 2.8- and 6.9-fold higher in carriers of MCP-1 genotypes AG and GG than in homozygous AA. Our findings suggest that persons bearing the MCP-1 genotype GG produce high concentrations of MCP-1, which inhibits production of IL-12p40 in response to M. tuberculosis and increases the likelihood that M. tuberculosis infection will progress to active pulmonary tuberculosis.


Abbreviations used: ANOVA, analysis of variance; BCG, Bacillus Calmette-Guerin; BMI, body mass index; CI, confidence interval; MCP-1, monocyte chemoattractant protein–1; MIP-1{alpha}, macrophage inflammatory protein–1{alpha}; NOS2A, nitric oxide synthase 2A; OR, odds ratio; RANTES, regulated on activation, normal T cell expressed and secreted; SNP, single nucleotide polymorphism.

P.O. Flores-Villanueva and J.A. Ruiz-Morales contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Chemokine drives tuberculosis
Heather L. Van Epps
J. Exp. Med. 2005 202: 1614. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS